Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

4000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-09-01

Study Completion Date

2028-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a large-scale observational study aiming to evaluate the long-term effectiveness and safety of Fecal Microbiota Transplantation (FMT). FMT is a procedure that transfers gut bacteria from healthy donors to patients to restore a balanced gut microbiome.

The study will follow approximately 4,000 patients who have received or will receive FMT for conditions like recurrent C. difficile infection, inflammatory bowel disease, functional gastrointestinal disorders, and certain neurological conditions.

The main goals are to:

* Assess the disease remission rates at 3 months, 1 year, and 5 years after FMT.
* Monitor the long-term safety and any potential side effects.
* Identify factors that may influence how well a patient responds to the treatment.

This research will use both existing patient data (retrospective cohort) and newly collected data from future patients (prospective cohort). The findings are expected to help improve and standardize FMT treatment for better patient care.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical Efficacy and Safety of Fecal Microbiota Transplantation

NCT04900051

Fecal Microbiota Transplantation

UNKNOWN

Explore Efficacy of FMT Treating Childhood ASD Patients

NCT04142255

ASD Accompanied by Moderate to Severe Gastrointestinal Symptoms

TERMINATED EARLY_PHASE1

Fecal Microbiome Transplant

NCT02636517

Clostridium Difficile Inflammatory Bowel Disease Crohn's Disease +1 more

ENROLLING_BY_INVITATION PHASE1

Safety of FMT: OpenBiome Outcomes and Longitudinal Follow-up (STOOL) for Recurrent Clostridium Difficile Infection

NCT02403622

Clostridium Difficile

TERMINATED PHASE2

The Dynamic Fluctuation of Donor Microbiota Affects the Prognosis of Fecal Microbiota Transplantation for C. Difficile Infection

NCT05703477

Clostridium Difficile Infection Fecal Microbiota Transplantation

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a single-center, real-world observational study combining retrospective and prospective cohorts to systematically evaluate the long-term effectiveness and safety of Fecal Microbiota Transplantation (FMT).

The study plans to enroll approximately 4,000 patients who have undergone FMT for a range of diseases, including recurrent Clostridium difficile infection, inflammatory bowel disease, functional gastrointestinal diseases, and certain extra-intestinal disorders.

The primary objective is to assess the real-world clinical remission rates at 3 months, 1 year, and 5 years post-FMT. Secondary objectives include evaluating long-term safety and adverse events, measuring improvements in quality of life, and exploring factors (such as delivery route, donor selection, and patient characteristics) that predict treatment success. Data will be collected from medical records and through planned follow-up visits. Advanced statistical and machine learning models will be used to analyze the data and build predictive models.

The results of this large-scale study will provide high-quality evidence to support the standardized and precise clinical application of FMT.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Clostridium Difficile Infection Recurrence Ulcerative Colitis (UC) Crohn Disease (CD) Irritable Bowel Syndrome (IBS) Chronic Functional Constipation Chemotherapy-Induced Colitis PD-1 Associated Enteritis Autism Spectrum Disorder Incomplete Intestinal Obstruction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.